Panelists share final thoughts and advice regarding the critical role pharmacy has played and continues to play in public health initiatives.
N-Acetylcysteine has several clinical uses. These include detoxification in acetaminophen overdose and improving outcomes in COPD exacerbations.
When making coverage decisions in oncology, payers find difficulties in translating evidence on treatment effect heterogeneity into coverage policies.
Through clinical and humanistic interventions, pharmacists can improve outcomes and lower costs for patients with diabetes.
McKaya Schmit guided patients through a natural disaster.
Patients who have received a transplant and are non-adherent to their medication regimens are more likely to experience graft failure and higher health care costs.
2017 Law Gives Pharmacies Ability to Help Patients Select and Adjust Devices
An estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.
Erlotinib may confer an economic advantage for payers over docetaxel and pemetrexed for second-line treatment of lung cancer because of lower costs.
A value-based benefit design program for prescription medications for asthma, hypertension, and diabetes could result in increased prescription use and decreased healthcare utilization and costs.
Advances in biotechnology have improved the production and recombination of antibodies, leading to improvements in monoclonal antibody therapies.
Pharmacists can learn about issues relating to the use of contact lens cleaning solutions.
Pharmacists' communication activities are critical to improving and maintaining a positive image among the public; therefore, a media plan should be in place in order to reach both broad and narrowly defined audiences.
This commentary addresses the possible reasons for treatment gaps between recommended therapy for patients with CKD, and the realities of current practices, and examines new developments that may bridge the gap.
Some states are considering and enacting legislation for programs aligning patients’ refill schedules.
Pharmacists in all health care settings play an important role in the prevention and treatment of diabetic neuropathy.
What do you imagine when you hear the word “brand”?
Pharmacy is a service profession in which we have the utmost responsibility to improve outcomes, lower cost, and improve the quality of life for patients with all types of health conditions.
This study of patients treated with pregabalin or duloxetine found that pregabalin prior authorization policies were associated with increased exposure to potential medication-medication and medication-condition interactions.
Personalized precision medical care addresses as many unique characteristics of the patient as possible.
Specialty pharmacies are the primary provider of oncology-related medication therapy.
As the wife of a collegiate basketball coach, I have lived in 7 states over 8 years; moving is simply a part of the game.
Examination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.